Daisuke Furukawa

Daisuke Furukawa practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Daisuke Furukawa's NPI, 1326434614, was assigned on April 13, 2015. Daisuke Furukawa graduated from David Geffen School of Medicine at UCLA in 2015. Daisuke Furukawa holds California license A148399.

Daisuke Furukawa's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Daisuke Furukawa's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Daisuke Furukawa to 1 more hospital and 1 medical group, each named with a free account. Daisuke Furukawa's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Daisuke Furukawa practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Daisuke Furukawa's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Daisuke Furukawa is board certified in infectious disease by the American Board of Internal Medicine. Daisuke Furukawa is licensed in California.

Dmand AI lists acute skin infection, joint or bone infection and UTI among the conditions Daisuke Furukawa treats.

CMS data shows 616 Medicare services from Daisuke Furukawa across 9 procedure codes in 2024, for 215 Medicare patients. Medicare paid $60,712 for them.

CMS counts 215 Medicare patients who saw Daisuke Furukawa in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daisuke Furukawa's median patient age at 58, with 44% women.

In 2024, Daisuke Furukawa wrote 474 Medicare Part D claims for 95 patients. 99% of them were for generic drugs. CMS names the drug for 400 of them, across 14 drugs with 11 or more claims each, at $25,696 in total drug cost. In 2023, CMS named 356 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Daisuke Furukawa for performance year 2024, reported as part of a group. Daisuke Furukawa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Daisuke Furukawa as offering telehealth.

Dmand AI links 7 papers to Daisuke Furukawa, published from 2024 to 2025. 2024 was the busiest year, with 2. Daisuke Furukawa's most frequent co-authors are Derek Fakhredean Amanatullah, MD, Jenny Ruth Aronson, MD and Paul Laszlo Bollyky, MD, PhD.

CMS Open Payments shows 3 general payments to Daisuke Furukawa from 3 drug and device companies from 2020 to 2025. Travel and lodging make up the largest share, 58% of the total. Globus Medical, Inc. paid the most, $162.

Daisuke Furukawa graduated from David Geffen School of Medicine at UCLA in 2015.

Daisuke Furukawa is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.